The development
Bayer announced a €2 billion hybrid bond placement on September 23, 2026. The two €1 billion tranches have 30 year maturities, initial coupons of 5.75% and 6.25%, and first ordinary call opportunities after six and nine years respectively. The company described the proceeds as available for general corporate purposes.
Source: Bayer financing announcement, September 23, 2026.
FOLITIC analysis: a call belongs to the issuer
A first call date is an opportunity for the issuer to repay under the terms, not a promise to the investor that repayment will occur. If refinancing becomes unattractive, the expected life of a hybrid can differ materially from a simple assumption that it will be called at the earliest date.
That creates an additional valuation question beyond the opening coupon. Investors need to examine the reset formula, ranking and any interest deferral provisions in the actual documentation. A high coupon cannot be compared fairly with senior debt without those differences.
How to compare the two tranches
Use scenarios in which each bond is called and scenarios in which it remains outstanding. The longer period before the first call changes exposure to credit conditions and market rates. The coupon difference is only one input.
For an equity investor, hybrid financing can support funding flexibility while creating obligations and claims ahead of common shares. The issuance itself does not prove that operating cash flow has improved. The analysis should connect the new financing with the company’s broader debt profile and future capacity to service its capital structure.
Photo: File photograph of Carl Duisberg Park in Leverkusen, illustrating the location associated with Bayer. Credit: Atamari via Wikimedia Commons. Image license: CC BY SA 3.0. Displayed with a responsive crop. This file photograph illustrates the subject or location and does not depict the reported transaction.
